CBUS Cibus, Inc.
Healthcare$1.43+3.62%ClosedMarket Cap: $65.0M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
25.36
P/S
14.65
EV/EBITDA
-4.95
DCF Value
$-0.65
FCF Yield
-80.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
72.1%
Operating Margin
-1375.7%
Net Margin
-2366.3%
ROE
-225.6%
ROA
-31.3%
ROIC
-18.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $1.7M | 28.8% | $-12.1M | $-21.2M | $— | — |
| Q4 null | $1.1M | 100.0% | $-13.5M | $-31.3M | $— | — |
| FY null | $3.6M | -62.8% | $-67.5M | $-127.1M | $— | — |
| Q3 null | $615.0K | 100.0% | $-15.4M | $-23.5M | $— | — |
| Q2 null | $933.0K | 100.0% | $-17.9M | $-25.4M | $— | — |
| Q1 null | $1.0M | 100.0% | $-20.6M | $-46.9M | $— | — |
| Q4 null | $1.2M | 100.0% | $-18.0M | $-23.1M | $— | — |
| FY null | $4.3M | 100.0% | $-258.4M | $-251.4M | $— | — |
| Q3 null | $1.7M | 100.0% | $-200.4M | $-180.0M | $— | — |
| Q2 null | $838.0K | -106.8% | $-21.5M | $-24.9M | $— | — |
| Q1 null | $545.0K | -224.2% | $-18.5M | $-23.4M | $— | — |
| Q4 2023 | $1.1M | -64.8% | $-19.9M | $-217.1M | $-12.02 | — |